Ca2+ uptake and the effect of the uptake inhibitors palmitoyl-CoA and palmitoylcarnitine were examined in two preparations of dog cardiac mitochondria. Mitochondria prepared by using the Nagarse technique was 2.5-fold more active in respirationdependent Ca2+ uptake than were mitochondria isolated by using the Polytron procedure. Palmitoyl-CoA and palmitoylcarnitine inhibited Ca2+ uptake in both preparations uncompetitively, with K1,app 0.4 and 20M. Ca2+-uptake rates were related to, or influenced by, the concentration of mitochondrial reduced nicotinamide nucleotides, with uptake slowing as this concentration decreased. When most of the nicotinamide nucleotides was oxidized, Ca2+ release and respiratory stimulation were observed. In the presence of Ruthenium Red and palmitoyl-CoA, oxidation of nicotinamide nucleotides was abolished and the time to Ca2+ release was shortened corresponding to the time of onset of nicotinamide nucleotide oxidation in the absence of Ruthenium Red. The results suggest that NAD(P)H oxidation in the presence of rotenone was a consequence of Ca2+ re-uptake and that net Ca2+ release could be observed as reduced nicotinamide nucleotide concentrations declined. Although nicotinamide nucleotide oxidation occurred in the presence of rotenone, it was not linked in an apparent manner to acyl-group metabolism (palmitoylcarnitine was less effective than palmitoyl-CoA). Therefore either a by-pass of the rotenone block or a direct interaction of NAD(P)H with the Ca2+-uptake process was possible. Loss of NADH occurred before respiratory stimulation, and this loss may relate to decreased coupling efficiency at sites 2 and 3 of the respiratory chain, as suggested by others [Bhuvaneswaran & Wadkins (1978) Biochem. Biophys. Res. Commun. 82, 
Ca2+ uptake and the effect of the uptake inhibitors palmitoyl-CoA and palmitoylcarnitine were examined in two preparations of dog cardiac mitochondria. Mitochondria prepared by using the Nagarse technique was 2.5-fold more active in respirationdependent Ca2+ uptake than were mitochondria isolated by using the Polytron procedure. Palmitoyl-CoA and palmitoylcarnitine inhibited Ca2+ uptake in both preparations uncompetitively, with K1,app 0.4 and 20M. Ca2+-uptake rates were related to, or influenced by, the concentration of mitochondrial reduced nicotinamide nucleotides, with uptake slowing as this concentration decreased. When most of the nicotinamide nucleotides was oxidized, Ca2+ release and respiratory stimulation were observed. In the presence of Ruthenium Red and palmitoyl-CoA, oxidation of nicotinamide nucleotides was abolished and the time to Ca2+ release was shortened corresponding to the time of onset of nicotinamide nucleotide oxidation in the absence of Ruthenium Red. The results suggest that NAD(P)H oxidation in the presence of rotenone was a consequence of Ca2+ re-uptake and that net Ca2+ release could be observed as reduced nicotinamide nucleotide concentrations declined. Although nicotinamide nucleotide oxidation occurred in the presence of rotenone, it was not linked in an apparent manner to acyl-group metabolism (palmitoylcarnitine was less effective than palmitoyl-CoA). Therefore either a by-pass of the rotenone block or a direct interaction of NAD(P)H with the Ca2+-uptake process was possible. Loss of NADH occurred before respiratory stimulation, and this loss may relate to decreased coupling efficiency at sites 2 and 3 of the respiratory chain, as suggested by others [Bhuvaneswaran & Wadkins (1978) Biochem. Biophys. Res. Commun. 82, The ability of a variety of mitochondrial preparations to transport and retain Ca2+ has been intensively studied (Chance, 1965;  Lehninger, 1970) . Factors that modulate the rates of Ca2+ influx, e.g. Mg2+ (Scarpa & Graziotti, 1973; Hutson et al., 1976) , have been implicated as a physiological control over mitochondrial Ca2+ loading. However, information about mechanisms that operate to discharge mitochondrial Ca2+ has emerged more recently. A variety of naturally occurring agents such as phosphoenolpyruvate (Chudapongse & Haugaard, 1973) , palmitoyl-CoA (Asimakis & Sordahl, 1977) , lysophosphatidylcholine (Harris, 1977) and Na+ (Crompton et al., 1977) have been shown to effect Ca2+ release from mitochondria. The redox state of mitochondrial nicotinamide nucleotides has been proposed to control Ca2+ moveVol. 186 ments, with a more oxidized state promoting Ca2+ efflux (Lehninger et al., 1978) . Cycles of Ca2+ uptake and release from mitochondria must occur in a readily reversible manner if the Ca2+-influx and -efflux pathways are to play a role in the control of either cytosolic or matrix Ca2+-affected metabolic pathways.
We have demonstrated that the non-penetrant metabolite palmitoyl-CoA causes a net oxidation of mitochondrial nicotinamide nucleotides in the presence of succinate and rotenone, with a concomitant efflux of accumulated Ca2+ (Wolkowicz & McMillin-Wood, 1979 (Harris, 1977) . It is known that different procedures for isolation of mitochondria profoundly influence the Ca2+-uptake properties of these organelles. Early studies suggest that use of the proteolytic enzyme Nagarse interferes with the ability of heart mitochondria to transport Ca2+ (Scarpa & Graziotti, 1973) . A more recent publication about the use of Nagarse describes an isolation procedure yielding mitochondria with improved respiratory activity as well as respiration-coupled Ca2+ accumulation (Vercesi et al., 1978) . This work is in agreement with a previous report where heart mitochondria isolated by using Nagarase were 1.5-fold more active than mitochondria obtained by using the Polytron procedure (Palmer et al., 1977) . In the present study we have examined Ca2+ uptake in these two different preparations of cardiac mitochondria (Palmer et al., 1977) as well as the effect of the lipid metabolites palmitoyl-CoA and palmitoylcarnitine on the Ca2+-influx and -efflux cycles.
Experimental
Isolation ofheart mitochondria Dog heart mitochondria were isolated from 5 g of left ventricle by the procedure of Palmer et al. (1977) . The tissue was finely minced in cold isolation medium A [220mM-mannitol/70mM-sucrose/ 5 mM-Mops (4-morpholinepropanesulphonic acid) buffer, pH 7.41 and adjusted to a final concentration of lOg of tissue/100ml of medium A containing 2 mM-EGTA and 0.2% bovine serum albumin. The minced tissue was homogenized with a Polytron tissue processor (Brinkman Instruments) for 25 s at a rheostat setting of 10. The homogenate was centrifuged at 5OOg in a Sorvall RC-2B centrifuge (SS-34 rotor) for 10min. The low-speed pellet was rehomogenized after resuspension to the original volume and centrifuged at 500g. The two supernatants were combined and the mitochondrial pellet was obtained by centrifugation at 3000g for 10min. The Polytron-prepared mitochondria were washed twice in medium A in the absence of EGTA and suspended in this medium at a protein concentration of 20-25 mg/ml for Ca2+-uptake studies.
The washed pellet from the 5OOg spin from the Polytron homogenization was resuspended in isolation medium B (100mM-KCl/50mM-Mops buffer, pH 7.4, containing 2 mM-EGTA and 0.2% bovine serum albumin). Nagarse was added, to a final concentration of 5 mg/g wet wt. of tissue, directly in the Potter-Elvehjem homogenizing vessel. After one pass with the pestle, the homogenate was immediately diluted 2-fold with medium B and centrifuged at 50OOg for 5min. The pellet was resuspended in the original volume of medium B and sedimented at 5OOg for 10min. The low-speed pellet was washed twice with medium B and the supernatants from the 5OOg spins were combined and re-centrifuged at 3000g for 10min. The pellet was washed twice in medium A in the absence of EGTA and resuspended in this medium at a final concentration of 25 mg/ml for Ca2+-uptake studies.
Protein was determined by the biuret procedure (Layne, 1957 The oxidation state of mitochondrial nicotinamide nucleotides was followed under the same incubation conditions as described for Ca2+ uptake and relase except that the metallochromic dye was omitted. The wavelength pair 340-370nm was employed to follow redox changes in nicotinamide nucleotides.
Changes in pH were recorded at 300C, in 4.5ml of Ca2+-uptake medium, containing 1.67mM-potassium phosphate buffer, pH7.2, 1.67mM-succinate, 20,ug of rotenone 73 mM-KCl in 0.25 Msucrose/I mM-Hepes buffer, pH 7.2, at a protein concentration of 0.9 mg/ml, by using a Radiometer type PH M22s pH-meter (Radiometer, Copenhagen, Denmark) (Fletcher et al., 1961) . Arsenazo III (Sigma Chemical Co.) was purified as described by Kendrick (1976 (Palmer et al., 1977) .
Initial rates of Ca2+ uptake were followed at various Ca2+ concentrations. The Polytron-prepared mitochondria demonstrated significantly lower rates of uptake, and saturation occurred at lower Ca2+ concentrations than with the Nagarse-prepared mitochondria (Fig. la) . The Km and V... were about 3-fold higher for the Nagarse-prepared mitochondria, i.e. Km 32pM and Vmax 4 10 nmol/min per mg for Polytron-prepared mitochondria, compared with Km 91pUM and Vmax 1176 nmol/min per mg for Nagarse-prepared mitochondria. These results support the contention of others (Vercesi et al., 1978) that the Nagarse procedure yields a heart mitochondrial preparation that is superior with respect to both respiratory capabilities and the capacity for Ca2+ accumulation.
Effects of palmitoyl-CoA and palmitoylcarnitine on Ca2+ uptake and Ca2+ efflux
The membrane-impermeant lipid palmitoyl-CoA has been shown to cause inhibition of Ca2+ uptake by mitochondria and premature aerobic release of previously accumulated Ca2+. The ability of carniVol. 186 tine to lessen the inhibitory effect of palmitoyl-CoA on Ca2+ uptake is believed to be a consequence of palmitoylcarnitine formation and transfer to the mitochondrial matrix (Asimakis & Sordahl, 1977; Harris, 1977 IPalmitoylcarnitinel (,UM) Fig. 2 . Preincubation ofdog heart mitochondria with palmitoylcarnitine: inhibition of Ca2+-uptake rates Dog heart mitochondria (2.5 mg) were preincubated in Ca2+-uptake medium described in Fig. 1 legend, with or without various concentrations of palmitoylcarnitine. Ca2+ uptake was initiated by injection of 67,uM-Ca2 . 0, Nagarse-prepared mitochondria, n = 3-7 separate determinations (±S.E.M.); 0, Polytron-prepared mitochondria, n = 3-6 separate determinations (± S.E.M.)
1977; Pitts et al., 1978) . Differing permeability characteristics and/or an increased fragility of the Polytron-prepared mitochondrial membranes has been proposed to explain the respiratory differences between the two mitochondrial preparations (Matlib et al., 1978) . Therefore it was decided to ascertain if any possible differences in the susceptibility of Ca2+ uptake by the two mitochondrial preparations to palmitoylcarnitine addition exist. Preincubation of mitochondria with various concentrations of palmitoylcarnitine resulted in a concentration-dependent decrease in Ca2+ uptake (Fig. 2) . The slopes of the lines suggest that increasing concentrations of palmitoylcarnitine affect Ca2+ uptake by both mitochondrial preparations similarly. Further experiments were performed to determine the kinetics of inhibition of Ca2+ accumulation by low concentrations of palmitoyl-CoA and palmitoylcarnitine.
Analysis of Ca2+ uptake in the presence of 2#uM-palmitoyl-CoA and/or 10,uM-palmitoylcarnitine is shown in Fig. 3 . Hanes-Woolf plots (Segal, 1975) (Fig. 3b) Table 1 . Since palmitoyl-CoA and palmitoylcarnitine affected both mitochondrial preparations similarly, the remainder of the studies were carried out by using the Nagarse isolation procedure. The latter procedure is desirable experimentally owing to higher mitochondrial yields and greater Ca2+-uptake capacities.
When palmitoyl-CoA concentration was varied over the range 1-4UM, a re-plot of Km-lI showed a linear response as a function of palmitoyl-CoA concentrations (Fig. 4, inset) . Thus the effect of palmitoyl-CoA on mitochondrial Ca2+ uptake appeared to represent pure uncompetitive-inhibition kinetics, rather than a mixed hyperbolic response. In addition, the results appear to contraindicate deleterious membrane effects. The K, for palmitoyl-CoA determined by the re-plot in this Figure is 0.4,uM.
Since palmitoylcarnitine decreases Ca2+ uptake in a manner kinetically similar to that of palmitoylCoA, albeit at higher concentrations, and since palmitoyl-CoA is known to cause Ca2+ efflux, the ability of palmitoylcarnitine to release Ca2+ was investigated. With Arsenazo III as the indicator dye, mitochondria were allowed to accumulate a small amount of Ca2+ (17 nmol/mg). After uptake, various concentrations of palmitoylcarnitine were injected (Fig. 5) . A rapid efflux of Ca2+ was observed, with the rates of efflux dependent on the concentration of palmitoylcarnitine injected. However, the release of Ca2+ stimulated by palmitoylcarnitine differed from palmitoyl-CoA-induced release in three ways: (1) release was immediate at all concentrations of palmitoylcarnitine used whereas with palmitoyl-CoA a concentration-dependent lag period was observed before release; (2) only a fraction of the total Ca2+ accumulated was released, whereas palmitoyl-CoA caused release of most of the accumulated Ca2+; (3) an occasional slow re-uptake of the released Ca2+ could occur in some preparations of Nagarse-prepared mitochondria, whereas addition of ATP or carnitine was necessary to reverse the palmitoylCoA-induced release (Harris, 1977) .
To eliminate the possibility that the release and reuptake observed were a consequence of either the low Ca2+ concentration used in the present study or of the high affinity of Arsenazo III for Ca2 , the experiment was repeated with tetramethylmurexide ( Fig.   6 ). Injection of 13.3 ,M-palmitoylcarnitine after mitochondrial Ca2+ accumulation resulted in a rapid release phase with a subsequent low rate of reuptake; when re-uptake was completed, addition of 2.6pM-palmitoyl-CoA produced a rapid release of accumulated Ca2+ and no re-uptake was observed (Fig. 6a) .
Since Ca2+ efflux from mitochondria appeared to be associated with a more oxidized state of mitochondrial nicotinamide nucleotides, with uptake dependent on the lower concentration of NADH, the effects of palmitoylcarnitine and palmitoyl-CoA on 370-340nm absorbance changes were followed. After mitochondria had accumulated Ca2+, injection of palmitoylcarnitine produced a rapid oxidation of nicotinamide nucleotides (Fig. 6b) , which re- . Effiects of palmitoylcarnitine and palmitoyl-CoA on mitochondrial Ca2+ movements, nicotinamide nucleotide oxidation and proton movements Nagarse-prepared dog heart mitochondria were suspended in Ca2+-uptake medium (see Fig. 1 legend) . Each trace is representative of five separate runs and measurements made as follows. (a) Mitochondria (2.8 mg) were preincubated for 2min in Ca2+-uptake medium containing lOOpuM-tetramethylmurexide and 0.25 M-sucrose/lOmM-Hepes buffer, pH 7.2, final volume 3 ml. Ca2+ uptake was initiated by injection of CaCl2 (final concn. 4OpaM). At the completion of uptake, 13.3 pM-palmitoylcarnitine was injected and Ca2+ release and re-uptake were followed. At the completion of the reuptake cycle, 2.6,uM-palmitoyl-CoA was added to initiate Ca2+ release. Ca2+ movements were followed at 518-542 nm. (b) Conditions for Ca2+ uptake were identical with those described for (a), except that tetramethylmurexide was omitted from the uptake medium. The oxidation of mitochondrial nicotinamide nucleotides was monitored after additions of Ca2', palmitoylcarnitine and palmitoyl-CoA. Nicotinamide nucleotide oxidation was monitored at 37ot340nm. (c) Conditions for Ca2o uptake were identical with those described for (b), except that the Hepes concentration was lowered to 1 mrM to follow proton movements and a final volume of 4.5ml was used. Mitochondrial protein was adjusted to a concentration of 0.93 mg/ml, as for (a) and (b).
Changes in pH after addition of Ca2), palmitoylcarnitine and palmitoyl-CoA were recorded at 30°C, by using a Radiometer type PHM 22s pHmeter attached to a Sargent-Welch model SRLG recorder with expanded scale. mained oxidized even as re-uptake of Ca2+ proceeded (cf. Fig. 6a ). Subsequent addition of palmitoyl-CoA resulted in a further oxidation concomitant with the release of most of the Ca2+ from the mitochondria. Changes in pH during Ca2+ uptake, palmitoylcarnitine-induced release and re-up-1980 take and palmitoyl-CoA-mediated Ca2+ release are shown in Fig. 6(c) . With Ca2+ uptake, a rapid acidification of the media occurred. Addition of palmitoylcarnitine produced re-alkalinization concomitant with Ca2+ release, and a subsequent slow re-acidification as Ca2+ re-uptake proceeded. Palmitoyl-CoA-mediated Ca2+ efflux was accompanied by an alkalinization of the assay medium. ofpalmitoyl-CoA (a) Nagarse-prepared dog heart mitochondria (2.8 mg) were preincubated for 3 min in a medium containing lOO1M-tetramethylmurexide, 1.67 mmsuccinate, 1.67 mM-potassium phosphate buffer, pH 7.2, 50,ug of rotenone and 73 mM-KCI in 0.25M-sucrose/lOmM-Hepes buffer, pH 7.2, final volume 3 ml.
, Control trace; ----, trace in the presence of 4pM-palmitoyl-CoA; in both cases 53pM-CaCI2 was injected and Ca2+ uptake and release were followed at 518-542nm. (b) Nagarse-prepared dog heart mitochondria (2.8mg) were preincubated for 3min in a medium as for (a) Vol. 186 Since the data in Fig. 6 suggest that Ca2+ uptake (re-uptake, Fig. 6a ) could proceed, albeit slowly, under conditions in which there is major loss in concentration of reduced nicotinamide nucleotide after palmitoylcarnitine injection, the effects of preincubation of mitochondria in the presence and absence of palmitoyl-CoA on Ca2+-uptake rates and nicotinamide nucleotide oxidation were investigated. In the absence of palmitoyl-CoA, Ca2+ uptake by mitochondria was rapid and the Ca2+ accumulated was retained during the course of the assay (Fig. 7a) . Preincubation with palmitoyl-CoA showed a lower rate of Ca2+ uptake, with subsequent Ca2+ efflux occurring 1min after peak Ca2+ accumulation. In the control, a slight oxidation of nicotinamide nucleotides was observed on Ca2+ addition, with subsequent return to base-line absorbance. However, a low rate of oxidation took place towards the end of the assay period (Fig. 7b) . In contrast, when mitochondria were preincubated with palmitoylCoA, Ca2+ injection was accompanied by a significant oxidation of nicotinamide nucleotides, with a further oxidation preceding and becoming maximal as Ca2+ release ensued. The apparent oxidation of NADH did not appear to be due to nicotinamide nucleotide efflux from the mitochondria, as no externally reactive NAD+ could be detected in these experiments. When mitochondrial respiration was monitored under the same conditions, little or no effect on oxygen consumption could be seen under control uptake conditions (Fig. 7c) . In the presence of palmitoyl-CoA the respiration rate increased markedly at a time period when peak Ca2+ efflux and nicotinamide nucleotide oxidation had occurred.
Effects ofRuthenium Red
The observation that NADH oxidation preceded Ca2+ release in the presence of palmitoyl-CoA (and that Ca2+ was retained in control mitochondria as slow NADH oxidation proceeded) suggested that rapid re-uptake of released Ca2+ resulted in the lack of observed net Ca2+ efflux. This process was associated with and/or dependent on nicotinamide nucleotide reduction state. To examine this possibility, the effect of Ruthenium Red, a potent inhibitor of Ca2+ uptake, on net Ca2+ release from mitochondria and on nicotinamide nucleotide oxidation was followed. Ruthenium Red was injected into the cuvette after completion of Ca2+ uptake and before addition of palmitoyl-CoA or palmitoylcarnitine (Fig. 8) . Ruthenium Red added before Ca2+ completely abolished uptake, and added after Ca2+ had no effect on Ca2+ retention. Palmitoyl-CoA (2.6uM) added alone produced rapid Ca2+ efflux and nicotinamide nucleotide oxidation after a concentrationdependent lag phase. When Ruthenium Red was added before palmitoyl-CoA, Ca2+ effiux was observed, but the release began before that seen for Effects ofRuthenium Red on Ca2+ efflux and nicotinamide nucleotide oxidation in the presence and in the absence ofpalmitoyl-CoA andpalmitoylcarnitine Nagarse-prepared dog heart mitochondria were suspended in Ca2+-uptake medium. After a 2min preincubation period, 53pM-CaCl2 was injected. After Ca2+ was accumulated, the experimental protocol was varied as follows. palmitoyl-CoA alone and the rate and extent of Ca2+ release appeared to be decreased (Fig. 8a) . Interestingly, the oxidation of mitochondrial nicotinamide nucleotides after palmitoyl-CoA addition at this concentration was completely abolished by Ruthenium Red (Fig. 8b) . The effect of Ruthenium Red on palmitoylcamitine-induced release is shown in Figs. 8(c) 
Discussion
Two different preparations of heart mitochondria made by using the Polytron and Nagarse procedures as described by Palmer et al. (1977) were employed to examine respiration-supported Ca2+ uptake. The two mitochondrial preparations have been attributed to different subcellular localizations, with the Polytron procedure releasing mitochondria localized at the periphery of the cell, i.e. below the sarcolemma, and the Nagarse preparation specifically isolating a mitochondrial fraction associated with the myofibrils (Palmer et al., 1977) . Previous reports by Hulsmann et al. (1968) indicated that skeletal muscle contains two types of mitochondria, and their findings were subsequently extended to the heart (Hulsmann, 1970) . Our mitochondrial preparations from dog heart also demonstrate structural and functional integrity, with respiratory parameters for each preparation in the range of those reported for rat (Palmer et al., 1977) . In agreement with the respiratory data, the Nagarse-prepared mitochondria were almost 3-fold as active in accumulation of Ca2+. Although the Km for Ca2+ is from 3-fold (Polytron-prepared mitochondria) to 10-fold (Nagarse-prepared mitochondria) higher than values for heart mitochondria reported by using other methods of measurement (Crompton et al., 1976; Noack & Heinen, 1977) , the Km values of the former preparation are similar to those reported by using the murexide technique (Scarpa & Graziotti, 1973) . As discussed previously (Jacobus et al., 1975) , measurement of free Ca2+ in experiments utilizing metallochromic dyes is complicated by the ability of reagents to complex Ca2+, and such discrepancies may be invoked to explain the Km differences. However, since Ca2+-uptake rates and nico-1980 tinamide nucleotide reduction states of the two preparations respond similarly to palmitoyl-CoA and palmitoylcarnitine, the use of the Nagarse procedure is desirable with respect to total protein yield and activity.
Palmitoyl-CoA has been shown previously to effect Ca2+ release from Ca2+-loaded mitochondria (Asimakis & Sordahl, 1977) and to decrease the rate of Ca2+ uptake in heart mitochondria (Harris, 1977) . However, the kinetic mechanisms of these effects were not investigated. The (Idell-Wenger et al., 1978) , mitochondria may respond to Ca2+ in a manner described in the present and other studies (Asimakis & Sordahl, 1977; Harris, 1977) . Interestingly, mitochondria isolated from ischaemic dog myocardium accumulate Ca2+ at lower rates, and then release the sequestered Ca2+ prematurely (Schwartz etal., 1973) .
It has been suggested that the intramitochondrial nicotinamide nucleotide reduction state is directly linked to Ca2+ fluxes (Lehninger et al., 1978) . Thus a high concentration of NADH, as in the presence of succinate + rotenone, would promote rapid Ca2+ entry, whereas a shift to a more oxidized ratio, after addition of acetoacetate or oxaloacetate, would favour Ca2+ efflux. We have previously observed (Wolkowicz & McMillin-Wood, 1979 ) that palmitoyl-CoA alone decreases Ca2+ uptake in liver mitochondria and promotes a release of accumulated Ca2+ that is concomitant with nicotinamide nucleotide oxidation. This effect is totally reversed by the presence of carnitine, but is enhanced by malonylCoA in the presence of carnitine. Since malonylCoA is a highly specific inhibitor of the carnitine acyltransferase located on the external aspect of the mitochondrial inner membrane (McGarry et al., 1978) , these results suggest that the Ca2+-induced nicotinamide nucleotide oxidation is the result of palmitoyl-CoA binding to the outer surface of the mitochondrial inner membrane. Results from the present Vol. 186 study show that the addition of Ca2+ to heart mitochondria preincubated with palmitoyl-CoA produces a slight but instantaneous oxidation of nicotinamide nucleotides with a slowed Ca2+ uptake. Injection of palmitoylcarnitine after Ca2+ uptake produces oxidation of a fraction of the mitochondrial nicotinamide nucleotides that is accompanied by immediate Ca2+ release and slowed re-uptake of Ca2+ in this group of experiments.
Thus the results demonstrate that the rate of Ca2+ uptake is apparently related to and influenced by the reduction state of the nicotinamide nucleotides. The experiments further suggest that Ca2+ release may be related only indirectly to mitochondrial nicotinamide nucleotide oxidation, i.e. via stimulation of reuptake. Evidence for this is found in Figs. 7 and 8 .
Addition of palmitoyl-CoA results in a lag phase preceding release of accumulated Ca2+, as previously described (Asimakis & Sordahl, 1977; Wolkowicz & McMillin-Wood, 1979 ). In the presence of Ruthenium Red, this lag phase is shortened and Ca2+ release occurs at a lower rate. The onset of Ca2+ release in the presence of Ruthenium Red corresponds temporally to onset of nicotinamide nucleotide oxidation after addition of palmitoyl-CoA in the absence of Ruthenium Red. In the presence of Ruthenium Red, no alteration in nicotinamide nucleotide reduction state occurs. The possibility therefore exists that Ca2+ release is unaffected by Ruthenium Red and the longer lag period observed in the absence of Ruthenium Red is a result of re-uptake of released Ca2+. Thus the ability of palmitoylCoA to enhance the affinity of the uptake mechanism for Ca2+ could account for the lag period preceding rapid Ca2+ efflux and for the onset of nicotinamide nucleotide oxidation. The low initial rate of palmitoyl-CoA-induced Ca2+ efflux in the absence of Ruthenium Red appears to relate to the more oxidized state of the nicotinamide nucleotides, i.e. slowed re-uptake. When most of the nicotinamide nucleotides is oxidized, re-uptake is impaired and a rapid Ca2+ release ensues.
Rates of Ca2+ effiux after palmitoylcarnitine injection are higher when Ruthenium Red is present.
The concentration of NADH in these mitochondria appears to be sufficient to continue active re-uptake in the absence of transport inhibitor. Thus the enhanced rates observed in the presence of both palmitoylcarnitine and Ruthenium Red are most likely to be due to inhibited re-accumulation of Ca2+. A mechanism similar to that for palmitoyl-CoA can be invoked to explain the prevention by Ruthenium Red of nicotinamide nucleotide oxidation and augmented net Ca2+ release in response to palmitoylcamitine.
Although the precise mechanism coupling nicotinamide nucleotide oxidation to Ca2+ transport is uncertain, it is curious that these effects occur in the presence of rotenone and in a non-metabolically linked manner. Disappearance of the larger part of the reduced nicotinamide nucleotides occurs in the presence of rotenone and precedes rapid net Ca2+ release and respiratory stimulation. The results suggest either that these agents produce a by-pass of the rotenone block, or perhaps that the nicotinamide nucleotides respond directly to Ca2+ movements, specifically Ca2+ uptake. A previous report (Bhuvaneswaran & Wadkins, 1978) demonstrates that coupling of arsenate-uncoupled liver mitochondria in the presence of rotenone can be activated by ,/-hydroxybutyrate-mediated NAD+ reduction, and suggests that coupling at sites 2 and 3 of the respiratory chain is amenable to control by the reduction state of nicotinamide nucleotides remote from these sites. In agreement with these observations, our results suggest that depletion of mitochondrial NADH leads to stimulated rates of respiration in the presence of rotenone, or possibly decreased coupling efficiency at sites 2 and 3.
Thus the oxidation of nicotinamide nucleotides preceding a net Ca2+-release phase induced by acyl esters appears to be a direct consequence of Ca2+ cycling with a resultant dissipation of energy or coupling efficiency necessary to retain the accumulated ion. It is also proposed that acyl-CoA interacts directly and in a highly specific manner with the carrier-Ca2+ complex on the outer surface of the inner membrane. Questions that remain to be answered concern the apparent immediate Ca2+_ specific oxidation of nicotinamide nucleotides in the presence of a rotenone block as well as the mechanism by which palmitoyl-CoA induces Ca2+ cycling, even at low concentrations where no membrane alterations or uncoupling occur in the absence of added cations
